62 results on '"Gerszten, Robert E."'
Search Results
2. Protein-metabolite association studies identify novel proteomic determinants of metabolite levels in human plasma
3. Plasma Proteomic Kinetics in Response to Acute Exercise
4. CYP4F2 is a human-specific determinant of circulating N-acyl amino acid levels
5. Mixed meal tolerance testing highlights in diabetes altered branched-chain ketoacid metabolism and pathways associated with all-cause mortality
6. METABOLIC SIGNATURES OF CARDIAC DYSFUNCTION ARE ASSOCIATED WITH MULTIMORBIDITY AND POST-TRANSCATHETER AORTIC VALVE IMPLANTATION MORTALITY
7. Human iPSC-hepatocyte modeling of alpha-1 antitrypsin heterozygosity reveals metabolic dysregulation and cellular heterogeneity
8. Visualizing biomarkers and their association with clinical outcomes: A machine learning approach
9. Proteomic Profiles Of Left Ventricular Assist Device Implantation
10. ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD
11. Whole-genome sequencing in diverse subjects identifies genetic correlates of leukocyte traits: The NHLBI TOPMed program
12. Associations of circulating choline and its related metabolites with cardiometabolic biomarkers: an international pooled analysis
13. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions
14. Circulating trimethylamine N-oxide in association with diet and cardiometabolic biomarkers: an international pooled analysis
15. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions
16. EDEM3 Modulates Plasma Triglyceride Level through Its Regulation of LRP1 Expression
17. Identification of 102 Correlations between Serum Metabolites and Habitual Diet in a Metabolomics Study of the Prostate, Lung, Colorectal, and Ovarian Cancer Trial
18. Perspective: Dietary Biomarkers of Intake and Exposure—Exploration with Omics Approaches
19. Systemic Biomarkers of Lung Function and FEV 1 Decline Across Multiple Cohorts
20. Accelerating Biomarker Discovery Through Electronic Health Records, Automated Biobanking, and Proteomics
21. EDEM3 Modulates Plasma Triglyceride Level Through Its Regulation of LRP1 Expression
22. l-Alanine activates hepatic AMP-activated protein kinase and modulates systemic glucose metabolism
23. Plasma metabolite profiles, cellular cholesterol efflux, and non-traditional cardiovascular risk in patients with CKD
24. Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis
25. Urinary metabolites along with common and rare genetic variations are associated with incident chronic kidney disease
26. Activation of IRF1 in Human Adipocytes Leads to Phenotypes Associated with Metabolic Disease
27. Cisplatin Analogs Confer Protection against Cyanide Poisoning
28. Induced Pluripotent Stem Cell Differentiation Enables Functional Validation of GWAS Variants in Metabolic Disease
29. Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis
30. The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease
31. Metabolomic Profiling in Relation to New-Onset Atrial Fibrillation (from the Framingham Heart Study)
32. Metabolic Profiling of Right Ventricular-Pulmonary Vascular Function Reveals Circulating Biomarkers of Pulmonary Hypertension
33. Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
34. Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury
35. Understanding the Cellular and Molecular Mechanisms of Physical Activity-Induced Health Benefits
36. PTPMT1 Inhibition Lowers Glucose through Succinate Dehydrogenase Phosphorylation
37. Genetic Architecture of Insulin Resistance in the Mouse
38. Design, methods, baseline characteristics and interim results of the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study
39. Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
40. β-Aminoisobutyric Acid Induces Browning of White Fat and Hepatic β-Oxidation and Is Inversely Correlated with Cardiometabolic Risk Factors
41. Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus
42. Toward New Biomarkers of Cardiometabolic Diseases
43. A Genome-wide Association Study of the Human Metabolome in a Community-Based Cohort
44. Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
45. An In Vivo Zebrafish Screen Identifies Organophosphate Antidotes with Diverse Mechanisms of Action
46. Myocardial Ischemia Induced by Rapid Atrial Pacing Causes Troponin T Release Detectable by a Highly Sensitive Assay
47. Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients
48. Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: Analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY) - Thrombolysis in Myocardial Infarction (TIMI) 28
49. Pharmacological inhibition of BLT1 diminishes early abdominal aneurysm formation
50. Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.